Preclinical and clinical studies suggest that GLP-1RAs may reduce EAT volume/thickness, potentially exceeding overall weight loss, attenuate EAT inflammation and fibrosis, improve cardiomyocyte calcium handling, mitigate oxidative stress, and suppress pulmonary vein ectopy, thereby potentially reducing AF susceptibility and recurrence post-ablation
Compounding is often used when there are shortages of branded drugs or when a patient needs a specific dosage that isnt commercially available
Jumping both at once risks compounding nausea or appetite suppression beyond therapeutic intent
No Ipamorelin is selective for the ghrelin receptor (GHS-R1a) and does not stimulate ACTH, cortisol, or prolactin secretion the way earlier secretagogues like GHRP-6 or GHRP-2 did
Medications and medical procedures for high Lp(a): A couple of therapies for high Lp(a) have been well studied as well as new drugs in trials to target it.[ref] Talk with your doctor about: PCSK9 inhibitors over statins: Taking a statin has been shown to actually elevate Lp(a) levels a little bit